• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Tafasitamab Antibody – Human Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5819056

Tafasitamab (XmAb5574) is an FC-modified humanized monoclonal antibody targeting the human B-cell surface antigen CD19 for the study of diffuse large B-cell lymphoma. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Tafasitamab, Monoclonal Antibody
Full Product Name
Tafasitamab
Product Synonym Names
MOR00208; XmAb5574; Tafasitamab-cxix
Clonality
Monoclonal
Host
Human
Species Reactivity
Human
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
1422527-84-1
In_vitro
In a xenograft tumor model of disseminated BL mice, tafasitamab (2.5ug/kg, once on day 1) inhibited lymphoma growth[1].

Other Notes

Small volumes of anti-Tafasitamab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Tafasitamab purchase

MBS5819056 is an antibody targeting Tafasitamab. Reactive in Human. Host: Human.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000